Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 92
Page 127
... normal intestine . Specifically , the purpose of this paper was to deter- mine which cytokines regulate the proliferation of intestinal fibroblasts and their collagen production and to study the distribution of these cytokines in the ...
... normal intestine . Specifically , the purpose of this paper was to deter- mine which cytokines regulate the proliferation of intestinal fibroblasts and their collagen production and to study the distribution of these cytokines in the ...
Page 128
... normal intestinal fibroblasts ( 25 ± 4 % ) 11,12 These findings show for the first time that Crohn's disease intestinal fibro- blasts proliferate much faster than normal intestinal fibroblasts . IGF - 1 and bFGF markedly enhanced the ...
... normal intestinal fibroblasts ( 25 ± 4 % ) 11,12 These findings show for the first time that Crohn's disease intestinal fibro- blasts proliferate much faster than normal intestinal fibroblasts . IGF - 1 and bFGF markedly enhanced the ...
Page 161
... normal and fibrotic tissues may account for differential TGF - ẞ effects on matrix metabolism . MATRIX METALLOPROTEINASES IN IBD Connective tissue degradation during both normal tissue remodelling and in pathological conditions is ...
... normal and fibrotic tissues may account for differential TGF - ẞ effects on matrix metabolism . MATRIX METALLOPROTEINASES IN IBD Connective tissue degradation during both normal tissue remodelling and in pathological conditions is ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis